Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel versus androgen receptor signaling inhibitor (A... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel versus androgen receptor signaling inhibitor (ARSI) against chemo-naïve castration-resistant prostate cancer (CRPC): propensity score matched analysis in real world
0
Authors
Tatsuya Shimomura
12 more
Tatsuya Shimomura
•
Keiichiro Mori
10 more
•
Takahiro Kimura
Published
June 24, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
International Urology and Nephrology
Topics
Medicine
Cancer Oncology
Internal Medicine
Endocrinology
Urology
Show all topics
DOI
10.1007/s11255-024-04116-3
